Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26366435 | 0.83 | — | — | |
| SCHEMBL16687387 | 0.82 | CA1 (0.33) | — | |
| SCHEMBL13125395 | 0.78 | ENPP2 (0.36) | CYP1A2CYP2C9ALOX15ALOX12CYP2C19 | |
| SCHEMBL3319030 | 0.78 | CES2 (0.32) | — | |
| SCHEMBL29957806 | 0.78 | ENPP2 (0.36) | CYP1A2CYP2C9ALOX15ALOX12CYP2C19 | |
| SCHEMBL29661842 | 0.77 | CYP3A4 (0.39) | CYP1A2CYP2C9ALOX15ALOX12CYP2C19 | |
| SCHEMBL29071226 | 0.77 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL22866473 | 0.77 | CYP3A4 (0.39) | CYP1A2CYP2C9ALOX15ALOX12CYP2C19 | |
| SCHEMBL16687386 | 0.75 | — | — | |
| SCHEMBL16972220 | 0.75 | CA12 (0.34) | ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240130227-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2024-04-18 | — | — | US | disclosed |
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-11851423-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-12-26 | — | — | US | disclosed |
| EP-4249478-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2023-09-27 | — | — | EP | disclosed |
| EP-4249478-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2023-09-27 | — | — | EP | disclosed |
| CN-116635385-A | Heterocyclic compound, organic light-emitting element comprising same, and organic layer composition for organic light-emitting element | LT素材株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-116529237-A | Compound and organic light-emitting element comprising same | LT素材株式会社 | 2023-08-01 | — | — | CN | disclosed |
| WO-2022139179-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | 엘티소재주식회사 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022108141-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2022-05-27 | — | — | WO | disclosed |
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240130227-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | ORC3, ODC1, LEF1 | CYP1A2 87/4885CYP2C9 50/4885ALOX15 160/4885 |
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | CYP1A2 8/4885CYP2C9 11/4885ALOX15 504/4885 |
| US-11851423-B2 | Heterocyclic compound and organic light emitting device comprising the same | CRY1, CYP1A1, CRY2 | CYP1A2 6/4885CYP2C9 10/4885ALOX15 323/4885 |
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, CYP1A1 | CYP1A2 7/4885CYP2C9 13/4885ALOX15 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.